BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 10453043)

  • 41. Mapping of conformational IgE epitopes with peptide-specific monoclonal antibodies reveals simultaneous binding of different IgE antibodies to a surface patch on the major birch pollen allergen, Bet v 1.
    Gieras A; Cejka P; Blatt K; Focke-Tejkl M; Linhart B; Flicker S; Stoecklinger A; Marth K; Drescher A; Thalhamer J; Valent P; Majdic O; Valenta R
    J Immunol; 2011 May; 186(9):5333-44. PubMed ID: 21451110
    [TBL] [Abstract][Full Text] [Related]  

  • 42. IgE-facilitated antigen presentation: role in allergy and the influence of allergen immunotherapy.
    Wilcock LK; Francis JN; Durham SR
    Immunol Allergy Clin North Am; 2006 May; 26(2):333-47, viii-ix. PubMed ID: 16701148
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Replacement of murine sera by allergen-specific monoclonal IgE antibodies: a new approach for the characterisation of allergen extracts.
    Kaul S; Fötisch K; Karamloo F; Vieths S; Hoffmann A
    Dev Biol (Basel); 2002; 111():109-15. PubMed ID: 12678230
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Soybean allergy in patients allergic to birch pollen: clinical investigation and molecular characterization of allergens.
    Mittag D; Vieths S; Vogel L; Becker WM; Rihs HP; Helbling A; Wüthrich B; Ballmer-Weber BK
    J Allergy Clin Immunol; 2004 Jan; 113(1):148-54. PubMed ID: 14713921
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human IgG monoclonal antibodies that modulate the binding of specific IgE to birch pollen Bet v 1.
    Visco V; Dolecek C; Denépoux S; Le Mao J; Guret C; Rousset F; Guinnepain MT; Kraft D; Valenta R; Weyer A; Banchereau J; Labecque S
    J Immunol; 1996 Jul; 157(2):956-62. PubMed ID: 8752951
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bet v 1, the major birch pollen allergen, conjugated to crystalline bacterial cell surface proteins, expands allergen-specific T cells of the Th1/Th0 phenotype in vitro by induction of IL-12.
    Jahn-Schmid B; Siemann U; Zenker A; Bohle B; Messner P; Unger FM; Sleytr UB; Scheiner O; Kraft D; Ebner C
    Int Immunol; 1997 Dec; 9(12):1867-74. PubMed ID: 9466314
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of a human IgG4 antibody, BAB2, with specificity for the major Birch pollen allergen, Bet v 1 in Escherichia coli: recombinant BAB2 Fabs enhance the allergic reaction.
    Eibensteiner P; Denépoux S; Steinberger P; Kraft D; Visco V; Banchereau J; Lebecque S; Valenta R
    Int Arch Allergy Immunol; 1999; 118(2-4):190-2. PubMed ID: 10224374
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Triggering of specific Toll-like receptors and proinflammatory cytokines breaks allergen-specific T-cell tolerance in human tonsils and peripheral blood.
    Kücüksezer UC; Palomares O; Rückert B; Jartti T; Puhakka T; Nandy A; Gemicioğlu B; Fahrner HB; Jung A; Deniz G; Akdis CA; Akdis M
    J Allergy Clin Immunol; 2013 Mar; 131(3):875-85. PubMed ID: 23265862
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Allergen-induced IgE-dependent gut inflammation in a human PBMC-engrafted murine model of allergy.
    Weigmann B; Schughart N; Wiebe C; Sudowe S; Lehr HA; Jonuleit H; Vogel L; Becker C; Neurath MF; Grabbe S; Saloga J; Bellinghausen I
    J Allergy Clin Immunol; 2012 Apr; 129(4):1126-35. PubMed ID: 22236728
    [TBL] [Abstract][Full Text] [Related]  

  • 50. IgE mimotopes of birch pollen allergen Bet v 1 induce blocking IgG in mice.
    Ganglberger E; Grünberger K; Wiedermann U; Vermes M; Sponer B; Breiteneder H; Scheiner O; Boltz G; Jensen-Jarolim E
    Int Arch Allergy Immunol; 2001; 124(1-3):395-7. PubMed ID: 11307026
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Interleukin 4, total and allergen-specific immunoglobulin E antibodies in the blood of individuals with an atopic constitution].
    Paranos S; Pravica V; Bonaci B; Stojković-Mostarica M
    Srp Arh Celok Lek; 1998; 126(3-4):92-6. PubMed ID: 9863362
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulation and targeting of T-cell immune responses by IgE and IgG antibodies.
    Bheekha Escura R; Wasserbauer E; Hammerschmid F; Pearce A; Kidd P; Mudde GC
    Immunology; 1995 Nov; 86(3):343-50. PubMed ID: 8550069
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relationship between facilitated allergen presentation and the presence of allergen-specific IgE in serum of atopic patients.
    van der Heijden FL; van Neerven RJ; Kapsenberg ML
    Clin Exp Immunol; 1995 Feb; 99(2):289-93. PubMed ID: 7851024
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of the route of sensitization on local and systemic immune responses in a murine model of type I allergy.
    Repa A; Wild C; Hufnagl K; Winkler B; Bohle B; Pollak A; Wiedermann U
    Clin Exp Immunol; 2004 Jul; 137(1):12-8. PubMed ID: 15196238
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of a hypoallergenic recombinant Bet v 1 variant as a candidate for allergen-specific immunotherapy.
    Kahlert H; Suck R; Weber B; Nandy A; Wald M; Keller W; Cromwell O; Fiebig H
    Int Arch Allergy Immunol; 2008; 145(3):193-206. PubMed ID: 17912007
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bet v 1, the major birch pollen allergen, and Mal d 1, the major apple allergen, cross-react at the level of allergen-specific T helper cells.
    Fritsch R; Bohle B; Vollmann U; Wiedermann U; Jahn-Schmid B; Krebitz M; Breiteneder H; Kraft D; Ebner C
    J Allergy Clin Immunol; 1998 Oct; 102(4 Pt 1):679-86. PubMed ID: 9802379
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Grass pollen immunotherapy induces mucosal and peripheral IL-10 responses and blocking IgG activity.
    Nouri-Aria KT; Wachholz PA; Francis JN; Jacobson MR; Walker SM; Wilcock LK; Staple SQ; Aalberse RC; Till SJ; Durham SR
    J Immunol; 2004 Mar; 172(5):3252-9. PubMed ID: 14978133
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production.
    Cosmi L; Santarlasci V; Angeli R; Liotta F; Maggi L; Frosali F; Rossi O; Falagiani P; Riva G; Romagnani S; Annunziato F; Maggi E
    Clin Exp Allergy; 2006 Mar; 36(3):261-72. PubMed ID: 16499636
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Distinct characteristics of seasonal (Bet v 1) vs. perennial (Der p 1/Der p 2) allergen-specific CD4(+) T cell responses.
    Wambre E; Bonvalet M; Bodo VB; Maillère B; Leclert G; Moussu H; Von Hofe E; Louise A; Balazuc AM; Ebo D; Hoarau C; Garcia G; Van Overtvelt L; Moingeon P
    Clin Exp Allergy; 2011 Feb; 41(2):192-203. PubMed ID: 21105918
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A hypoallergenic variant of the major birch pollen allergen shows distinct characteristics in antigen processing and T-cell activation.
    Kitzmüller C; Wallner M; Deifl S; Mutschlechner S; Walterskirchen C; Zlabinger GJ; Ferreira F; Bohle B
    Allergy; 2012 Nov; 67(11):1375-82. PubMed ID: 22973879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.